Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Perspective Therapeutics, Inc.ISR · Entity 694 | Dir. of Operations, Secretary | June 23, 2020 | June 25, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Perspective Therapeutics, Inc.
Report date June 23, 2020 · Filed June 25, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.61 · Expires 2030-06-23 | Direct | 227,500 |
Reported balance
After 2020-06-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-23 · Grant · Acquired 30,000 · Balance 227,500 F1: 25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2020 Filed Jun 25, 2020 20:39 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001437749-20-013872 · rdgdoc.xml · derivative · entry 1 Cline Krista · CIK 0001758039 · Dir. of Operations, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,500 Underlying: Common Stock · 30,000 shares Expires 2030-06-23 F1 · derivative.exercise_date: 25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested. Read SEC document |
| May 30, 2019 Filed Sep 20, 2019 21:39 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionStock Options (right to buy) · Derivative | 21,900 | $0.00 Strike: $0.26 | $0.00 |
DisclosureSEC source: 0001437749-19-018834 · rdgdoc.xml · derivative · entry 2 Cline Krista · CIK 0001758039 · Dir. of Operations, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,500 Underlying: Common Stock · 21,900 shares Expires 2019-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: 21,900 stock options were granted on 6/1/2009. The shares were vested 6/1/2013. F1 · shares: 21,900 stock options were granted on 6/1/2009. The shares were vested 6/1/2013. F1 · derivative.exercise_date: 21,900 stock options were granted on 6/1/2009. The shares were vested 6/1/2013. F1 · derivative.underlying_shares: 21,900 stock options were granted on 6/1/2009. The shares were vested 6/1/2013. Read SEC document |
| May 30, 2019 Filed Sep 20, 2019 21:39 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionCommon Stock | 21,900 | $0.26 | $5,694.00 |
DisclosureSEC source: 0001437749-19-018834 · rdgdoc.xml · nonDerivative · entry 1 Cline Krista · CIK 0001758039 · Dir. of Operations, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.